Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEA 2180 BR vs Tiotropium in COPD
NCT00528996Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of bea 2180 in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2007; status: completed.
02
Drugs
bea 2180
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00528996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00528996.